Article
Inhibition of UBA6 by inosine augments tumour immunogenicity and responses
15 Sept 2022
Abstract excerpt
Anti-cancer immunity and response to immune therapy is influenced by the metabolic states of the tumours. Immune checkpoint blockade therapy (ICB) is known to involve metabolic adaptation, however, the mechanism is not fully known. Here we show, by metabolic profiling of plasma samples from melanoma-bearing mice undergoing anti-PD1 and anti-CTLA4 combination therapy, that higher levels of purine metabolites,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
